Palantir Just $300 Billion: Growth Sparks Mega-Cap Move
Palantir tops $300 billion in market value as Q1 2026 results reveal record growth and expanding margins. The milesto...
Which States Tax Mining Income 2026
Identify which states tax mining income in 2026 and grasp the key tax implications for miners. This primer covers rules you should know and steps to stay compliant.
26,499 articles
Pet Insurance Stocks: Top Performing Insurance Stocks in 2026
Pet insurance stocks are among the year's standout performers in the broader insurance space. This review highlights ...
IonQ Tripled Revenue, Yet Stock Dips as Losses Expand
IonQ posted triple-digit revenue growth for 2025, reaching a new high, while losses intensified. The stock has fallen...
Cardano’s Charles Hoskinson Outlines 2026 Funding Roadmap
Cardano is redefining its funding approach for 2026, prioritizing utility and user experience as market conditions ti...
Snowflake Stock Price Prediction for 2026, 2027 and 2030
Snowflake stock price prediction signals a pivotal path forward as AI-native cloud initiatives expand and profitabili...
Conagra Brands Invest $220 Million: Is It a Buy in 2026?
Conagra Brands is pouring $220 million into a key manufacturing upgrade, signaling confidence in demand. But does tha...
Artificial Intelligence (AI) Stock Could Roar Back by 2026
A well-known AI stock has retraced roughly a quarter from its high, creating a potential entry point for investors. T...
Samsung Stock Price Prediction: 2026, 2027 and 2030
Samsung Electronics faces volatility as AI-driven demand and memory cycles shape its path. This report outlines samsu...
What’s Best Crypto with $1,000: Bitcoin vs XRP in 2026
Bitcoin and XRP lead the 2026 debate on how to deploy $1,000 in crypto, with macro momentum and policy shifts potenti...
Barclays Thinks Ionis Headed Toward a $106 Target This Year
Barclays has boosted its Ionis target to $106, signaling a roughly 46% upside from recent levels as olezarsen eyes pe...
Phathom Pharma Upgraded by Barclays to Overweight $18 Target
Barclays lifts Phathom Pharmaceuticals to Overweight with an $18 target, citing a stronger 2026 revenue trajectory an...
2026 GameChanger: REMAX Select Drives Transaction Growth
REMAX Select reports a sharp rise in transaction sides driven by collaboration across markets, earning a top-10 place...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status